Verition Fund Management’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.01M | Buy |
290,599
+151,355
| +109% | +$524K | ﹤0.01% | 1851 |
|
|
2025
Q1 | $365K | Buy |
139,244
+48,770
| +54% | +$128K | ﹤0.01% | 2144 |
|
|
2024
Q4 | $373K | Buy |
90,474
+14,335
| +19% | +$59.1K | ﹤0.01% | 2032 |
|
|
2024
Q3 | $539K | Buy |
76,139
+62,320
| +451% | +$441K | ﹤0.01% | 1652 |
|
|
2024
Q2 | $90.1K | Sell |
13,819
-5,575
| -29% | -$36.3K | ﹤0.01% | 2089 |
|
|
2024
Q1 | $161K | Buy |
19,394
+3,224
| +20% | +$26.8K | ﹤0.01% | 1930 |
|
|
2023
Q4 | $178K | Sell |
16,170
-42,655
| -73% | -$470K | ﹤0.01% | 1624 |
|
|
2023
Q3 | $495K | Buy |
58,825
+24,387
| +71% | +$205K | 0.01% | 1189 |
|
|
2023
Q2 | $433K | Buy |
+34,438
| New | +$433K | 0.01% | 1130 |
|